Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium
- PMID: 26264275
- PMCID: PMC4538266
- DOI: 10.1136/bmjopen-2015-008808
Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium
Erratum in
-
Correction. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis.BMJ Open. 2015 Sep 28;5(9):e008808. doi: 10.1136/bmjopen-2015-008808corr1. BMJ Open. 2015. PMID: 26416512 Free PMC article. No abstract available.
Abstract
Objectives: To investigate, using a Mendelian randomisation approach, whether heavier smoking is associated with a range of regional adiposity phenotypes, in particular those related to abdominal adiposity.
Design: Mendelian randomisation meta-analyses using a genetic variant (rs16969968/rs1051730 in the CHRNA5-CHRNA3-CHRNB4 gene region) as a proxy for smoking heaviness, of the associations of smoking heaviness with a range of adiposity phenotypes.
Participants: 148,731 current, former and never-smokers of European ancestry aged ≥ 16 years from 29 studies in the consortium for Causal Analysis Research in Tobacco and Alcohol (CARTA).
Primary outcome measures: Waist and hip circumferences, and waist-hip ratio.
Results: The data included up to 66,809 never-smokers, 43,009 former smokers and 38,913 current daily cigarette smokers. Among current smokers, for each extra minor allele, the geometric mean was lower for waist circumference by -0.40% (95% CI -0.57% to -0.22%), with effects on hip circumference, waist-hip ratio and body mass index (BMI) being -0.31% (95% CI -0.42% to -0.19), -0.08% (-0.19% to 0.03%) and -0.74% (-0.96% to -0.51%), respectively. In contrast, among never-smokers, these effects were higher by 0.23% (0.09% to 0.36%), 0.17% (0.08% to 0.26%), 0.07% (-0.01% to 0.15%) and 0.35% (0.18% to 0.52%), respectively. When adjusting the three central adiposity measures for BMI, the effects among current smokers changed direction and were higher by 0.14% (0.05% to 0.22%) for waist circumference, 0.02% (-0.05% to 0.08%) for hip circumference and 0.10% (0.02% to 0.19%) for waist-hip ratio, for each extra minor allele.
Conclusions: For a given BMI, a gene variant associated with increased cigarette consumption was associated with increased waist circumference. Smoking in an effort to control weight may lead to accumulation of central adiposity.
Keywords: EPIDEMIOLOGY; GENETICS.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
References
-
- Doll R, Peto R, Boreham J et al. . Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519 10.1136/bmj.38142.554479.AE - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- K013351/MRC_/Medical Research Council/United Kingdom
- PG/13/66/30442/BHF_/British Heart Foundation/United Kingdom
- R01 HL036310/HL/NHLBI NIH HHS/United States
- R01 MH077874/MH/NIMH NIH HHS/United States
- 102215/WT_/Wellcome Trust/United Kingdom
- R01AG1764406S1/AG/NIA NIH HHS/United States
- MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom
- G0600705/MRC_/Medical Research Council/United Kingdom
- G1001799/MRC_/Medical Research Council/United Kingdom
- MC_UU_12019/1/MRC_/Medical Research Council/United Kingdom
- R01 MH063706/MH/NIMH NIH HHS/United States
- G1002319/MRC_/Medical Research Council/United Kingdom
- G0802736/MRC_/Medical Research Council/United Kingdom
- MH077874/MH/NIMH NIH HHS/United States
- R01 HL087679/HL/NHLBI NIH HHS/United States
- G0800612/MRC_/Medical Research Council/United Kingdom
- MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom
- R01 DA024413/DA/NIDA NIH HHS/United States
- MR/J01351X/1/MRC_/Medical Research Council/United Kingdom
- 068545/Z/02/WT_/Wellcome Trust/United Kingdom
- CZD/16/6/CSO_/Chief Scientist Office/United Kingdom
- PG/07/131/24254/BHF_/British Heart Foundation/United Kingdom
- 086684/WT_/Wellcome Trust/United Kingdom
- 5R01MH63706:02/MH/NIMH NIH HHS/United States
- AG13196/AG/NIA NIH HHS/United States
- MR/K023195/1/MRC_/Medical Research Council/United Kingdom
- MR/J012165/1/MRC_/Medical Research Council/United Kingdom
- RG/08/013/25942/BHF_/British Heart Foundation/United Kingdom
- 1RL1MH083268-01/MH/NIMH NIH HHS/United States
- 076113/WT_/Wellcome Trust/United Kingdom
- MC_UP_0801/1/MRC_/Medical Research Council/United Kingdom
- R37 AG013196/AG/NIA NIH HHS/United States
- MR/N01104X/1/MRC_/Medical Research Council/United Kingdom
- MR/K023233/1/MRC_/Medical Research Council/United Kingdom
- U01 DK062418/DK/NIDDK NIH HHS/United States
- 0090049/DH_/Department of Health/United Kingdom
- MC_PC_15018/MRC_/Medical Research Council/United Kingdom
- PG/09/022/BHF_/British Heart Foundation/United Kingdom
- HL36310/HL/NHLBI NIH HHS/United States
- 092731/WT_/Wellcome Trust/United Kingdom
- MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom
- R01DA024413/DA/NIDA NIH HHS/United States
- CZD/16/6/4/CSO_/Chief Scientist Office/United Kingdom
- MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom
- G0500539/MRC_/Medical Research Council/United Kingdom
- G0000934/MRC_/Medical Research Council/United Kingdom
- UL1 TR001425/TR/NCATS NIH HHS/United States
- R01 AG017644/AG/NIA NIH HHS/United States
- MR/K013351/1/MRC_/Medical Research Council/United Kingdom
- R01 AG013196/AG/NIA NIH HHS/United States
- 5R01HL087679-02/HL/NHLBI NIH HHS/United States
- HS06516/HS/AHRQ HHS/United States
- RG/13/16/30528/BHF_/British Heart Foundation/United Kingdom
- RL1 MH083268/MH/NIMH NIH HHS/United States
- MC_UU_12013/5/MRC_/Medical Research Council/United Kingdom
- WT 084762/WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical